[ Price : $8.95]
Federal Register Notice: FDA announces a 10/31 to 11/1 public meeting in College Park, MD to discuss scientific and technical issu...[ Price : $8.95]
Federal Register Final Rule: FDA issues a final rule to implement Title XI of the Medicare Prescription Drug, Improvement, and Mod...[ Price : $8.95]
Researchers say that data monitoring committees have complex responsibilities and may have to cope with unexpected developments du...[ Price : $8.95]
Attorney Kurt Karst says a new FDA final rule will forever alter the Waxman-Hatch landscape and will likely fuel controversies and...[ Price : $8.95]
Novartis pays over $35 million to settle a whistleblowers claims that it marketed Elidel for off-label use in infants and violated...[ Price : $8.95]
Nurse Assist recalls all unexpired lots of I.V. Flush Syringes due to a potential link to Burkholderia cepacia bloodstream infecti...[ Price : $8.95]
FDA grants Roches Actemra/RoActemra Breakthrough Therapy designation for giant cell arteritis.[ Price : $8.95]
FDA grants Chugai Pharmaceutical a breakthrough therapy designation for Actemra /RoActemra (tocilizumab), a Chugai-originated drug...